To read more on this topic click here.
New Parkinson’s trial platform could “dramatically speed up the search for a cure”
Author: Saskia MairPublished: 14 May 2020
Prep: Cook: Serves:
Scientists have proposed the use of a multi-arm, multi-stage trial platform (MAMS) to assess different potential treatments for Parkinson’s and help progress the search for a cure.
This would depart from conventional clinical procedures, allowing several potential treatments to be assessed simultaneously. In a continuous process, each treatment ‘arm’ is evaluated and unsuccessful ‘arms’ of the trial are dropped, enabling a far more cost and time efficient system.
Currently, MAMS are used to evaluate treatments for certain types of cancer – and work is underway to develop MAMS for other neurodegenerative conditions.
Camille Buchholz Carroll, associate professor at the University of Plymouth, UK, and study author, said that MAMS trials could “dramatically speed up the search for a cure”.
She said: “We have the opportunity to learn from the experience in these other conditions and design a new trial that will work for people with Parkinson’s.”
For more information on the latest Parkinson’s research please visit the EPDA website.
Share this story
The ‘Starbucks formula’: a new approach to Parkinson’s treatment that’s going global
Parkinson’s healthcare scheme where the patient is a partnerREAD MORE
The students breaking ground in Parkinson’s tech
An app that’s digitising the spiral testREAD MORE
Ask the expert: How does Parkinson’s disease impact dreams?
Dr Daniele Urso shares insights and advice on sleep disturbanceREAD MORE